3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Prostatic Neoplasms
2
Drug-Related Side Effects and Adverse Reactions
2
Cardiovascular Diseases
2
Cardiotoxicity
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Multiple Myeloma
1
Leukemia, Myeloid
1
Leukemia, Monocytic, Acute
1
Leukemia, Lymphoid
1
Leukemia
1
Kidney Neoplasms
1
Hodgkin Disease
1
Interventions
Echocardiography
6
Doxorubicin
3
Carvedilol
3
empagliflozin
2
Social Determinants of Health
2
Electrocardiography
2
Cyclophosphamide
2
pegfilgrastim
1
dapagliflozin
1
Watchful Waiting
1
Vincristine
1
Vascular Stiffness
1
Trastuzumab
1
Tablets
1
Standard of Care
1
Rosuvastatin Calcium
1
Rituximab
1
Resistance Training
1
Pulse Wave Analysis
1
Prednisolone
1
Palliative Care
1
Observation
1
Methods
1
Lenalidomide
1
Hematologic Tests
1
Fenofibrate
1
Exercise Test
1
Environmental Biomarkers
1
EGFR tyrosine kinase inhibitor 324674
1
Dexrazoxane
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Social Determinants of Health
×
1 year
×
Clear all
NCT05096338
2026-03-23
PCT
Abramson Cancer Center at Penn Medicine
Active not recruiting
200 enrolled
NCT05078190
2025-11-06
CCT2
Abramson Cancer Center at Penn Medicine
Active not recruiting
200 enrolled